RISK FACTORS AND CLINICAL OUTCOMES OF FEBRILE URINARY TRACT INFECTION FROM CEFTRIAXONE-RESISTANT ENTEROBACTERACEAE IN CHILDREN
Journal of Southeast Asian Medical Research · 2026
DOI: 10.55374/jseamed.v10.297 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Southeast Asian Medical Research, 2026. Verfasst von Kongrit Kunnaruk und 2 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Febrile urinary tract infection (FUTI) is one of the most common bacterial infections in children. It is a major cause of hospitalization and long-term renal complications, with Enterobacteriaceae being the main pathogens. Third-generation cephalosporins, particularly ceftriaxone, are widely used as first-line empirical antibiotics because of their broad-spectrum activity. Previous studies have shown that the prevalence of ceftriaxone-resistant Enterobacteriaceae is increasing both domestically and internationally. However, these studies have reported inconsistent findings regarding differences in clinical manifestations and treatment outcomes between ceftriaxone-resistant and ceftriaxonesusceptible FUTI.
Methods
We conducted a retrospective cohort study of pediatric patients diagnosed with Enterobacteriaceae-associated FUTI at Naresuan University Hospital, a tertiary hospital in the lower northern part of Thailand, from November 1, 2018, to October 31, 2024. Patients were categorized into ceftriaxone-resistant and susceptible groups. We analyzed clinical data, laboratory findings, treatment outcomes, and post-infectious imaging.
Results
Of the 52 pediatric cases, Escherichia coli was the most common pathogen (86.5%), with 77.8% ceftriaxone sensitivity. Patients with previous antibiotic use within 3 months and a history of hospitalization tended to have ceftriaxone resistance, though the difference was not significant. Moreover, patients with ceftriaxone-resistant FUTI had longer hospital stays and longer durations of intravenous antibiotic therapy; however, these differences were not statistically significant. Patients with FUTI due to ceftriaxone-resistant Enterobacteriaceae were more likely to require a change in antibiotic therapy than those with FUTI due to ceftriaxone-susceptible Enterobacteriaceae.
Conclusion
There is no significant difference in risk factors and treatment outcomes between ceftriaxone-resistant and susceptible Enterobacteriaceae FUTI. This finding indicates that third-generation cephalosporins can be used as an appropriate empirical therapy for community-onset FUTI. However, patients with FUTI should be promptly switched to targeted antimicrobials based on sensitivity results if they deteriorate clinically.
Zitieren
APA
Kunnaruk, K., Chuenchusilp, P., & Ngoenmak, T. (2026). RISK FACTORS AND CLINICAL OUTCOMES OF FEBRILE URINARY TRACT INFECTION FROM CEFTRIAXONE-RESISTANT ENTEROBACTERACEAE IN CHILDREN. Journal of Southeast Asian Medical Research. https://doi.org/10.55374/jseamed.v10.297
Vancouver
Kunnaruk K, Chuenchusilp P, Ngoenmak T. RISK FACTORS AND CLINICAL OUTCOMES OF FEBRILE URINARY TRACT INFECTION FROM CEFTRIAXONE-RESISTANT ENTEROBACTERACEAE IN CHILDREN. Journal of Southeast Asian Medical Research. 2026. doi:10.55374/jseamed.v10.297
BibTeX
@article{Kunnaruk2026,
author = {Kunnaruk, Kongrit and Chuenchusilp, Patthiya and Ngoenmak, Thitima},
title = {RISK FACTORS AND CLINICAL OUTCOMES OF FEBRILE URINARY TRACT INFECTION FROM CEFTRIAXONE-RESISTANT ENTEROBACTERACEAE IN CHILDREN},
journal = {Journal of Southeast Asian Medical Research},
year = {2026},
doi = {10.55374/jseamed.v10.297}
}
EUVIMED